Sign In

Jim Martineau

Co-Founder | AI for Programmable Therapeutics

Jim Martineau is the Co-Founder and CEO of Nosis Bio, a biotech startup focused on leveraging machine learning and biology to drive breakthroughs in healthcare. Based in the San Francisco Bay Area, he has over 15 years of experience at the intersection of data science and healthcare innovation. Before founding Nosis Bio in July 2021, Martineau served as Head of Product for Oncology at Natera, where he led the development of products like Signatera, a molecular residual disease test widely used in oncology. His work has been featured in prominent journals such as Nature and JAMA Oncology .123

Earlier in his career, Martineau held leadership roles at Flatiron Health (acquired by Roche for $2 billion), where he developed enterprise real-world data products for oncology, and co-founded Canvas Medical, a YCombinator-backed company. He also worked at organizations like Facebook, Practice Fusion, and ZS Associates .12

Martineau holds an MBA in Health Care Management from The Wharton School at the University of Pennsylvania, an MS in Computational & Mathematical Engineering from Stanford University, and a BS in Engineering Physics from Colorado School of Mines .2

Highlights

Jan 1 · nosisbio.com
Jim Martineau - Technologyc - Webflow Ecommerce Website Template
Jim Martineau - Technologyc - Webflow Ecommerce Website Template

Related Questions

What is Nosis Bio's mission?
How does Jim Martineau integrate machine learning into biology?
What are some notable achievements of Natera under Jim Martineau's leadership?
What was Jim Martineau's role at Flatiron Health?
How did Jim Martineau's experience at Facebook influence his career?
Jim Martineau
Jim Martineau, photo 1
Jim Martineau, photo 2
Add to my network

Location

San Francisco Bay Area